Country/Region: China
Main Products: Adefovir, Adefovir Dipivoxil, ZidovudineRitonavir, EfavirenzLamivudine, Lopinavir, Meropenem, Telicoplanin, Desogestrel, Capecitabine, Adefovir
Business Type: Manufacturer
Business Nature: Manufacturer
Year Established: 2005, 2005
Legal Status: Own Lisence
Ownership: LLC
Employees: Above 1000 People
Factory Size: 50, 000-100, 000 square meters
R&D Team Size: Fewer than 5
Certifications: BRC
Contact Person: annie wang
Designation: Account Manager
Department: Marketing
Telephone: 86-574-27669096
Main Markets: Ghana (28%) India (20%) Saudi Arabia (19%) Australia (19%) Canada (18%) United States (10%)
Export Focus: Australia, Canada, Ghana, India, Saudi Arabia, United States
Contract Services: OEM Service Offered
Annual Revenue: Approx More Than 1 Billion US Dollar
Registered Capital: US$10 Million - US$50 Million
Export Percentage: 41% - 50%
Payment Terms: Bank wire (T/T), Letter of Credit (L/C), Western Union (WU), Cash